Market capitalization | $23.95b |
Enterprise Value | $26.09b |
PER (TTM) P/E ratio | 43.58 |
EV/FCF (TTM) EV/FCF | 12.99 |
EV/Sales (TTM) EV/Sales | 0.12 |
P/S ratio (TTM) P/S ratio | 0.11 |
P/B ratio (TTM) P/B ratio | negative |
Dividend yield | 2.02% |
Last dividend (FY23) | $1.99 |
As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.
20 Analysts have issued a Cardinal Health forecast:
20 Analysts have issued a Cardinal Health forecast:
Mar '24 |
+/-
%
|
||
Turnover | 220,572 220,572 |
11%
11%
|
|
Gross income | 7,197 7,197 |
13%
13%
|
|
EBITDA | 2,868 2,868 |
22%
22%
|
EBIT (operating result) EBIT | 2,168 2,168 |
31%
31%
|
Net profit | 552 552 |
19%
19%
|
Figures in millions USD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
Head office | United States |
CEO | Jason Hollar |
Employees | 48,000 |
Founded | 1979 |
Website | www.cardinalhealth.com |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.